Home > Healthcare > Medical Devices > Therapeutic Devices > asthma spacers market
Get a free sample of Asthma Spacers Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Asthma Spacers Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
There is increasing awareness among healthcare providers and patients about the benefits of using asthma spacers in conjunction with metered-dose inhalers (MDIs). Spacers help optimize the delivery of medication to the lungs by reducing the need for precise coordination between inhaler activation and inhalation.
The aerochamber product segment accounted for USD 641.5 million in 2023 and is set to gain traction by 2032, due to its role in reducing the amount of medication deposited in the mouth and throat and minimizing the risk of side effects such as oral thrush and hoarseness.
Asthma spacers industry size was valued at USD 1.66 billion in 2023 and is estimated to reach over USD 2.67 billion by 2032, driven by the rising incidence and prevalence of chronic respiratory conditions.
North America asthma spacers industry size was USD 672.2 million in 2023 and is predicted to witness substantial market growth by 2032, driven by a sophisticated healthcare infrastructure, an increasing prevalence of respiratory conditions such as asthma, rapid technological advancements.
Cipla Inc., GlaxoSmithKline plc, Koninklijke Philips N.V., Koo Medical Equipment, Laboratoire ProtecSom, Lupin Limited, Mediacare Equipments (India) Pvt. Ltd, Monaghan Medical Corporation, PARI GmbH are some of the major industry contenders.